Ahsan Ejaz

Ahsan Ejaz

Auto-generated profile, based on publicly available information

Ahsan Ejaz

School of Nuclear Science and Technology, Lanzhou University, Lanzhou, People’s Republic of China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2007 in Nephron Clinical Practice
Verified
Journal Article
Closed access
AKAmir Kazory
Amir Kazory
WCWilliam L. Clapp
William L. Clapp
AEA. Ahsan Ejaz
A. Ahsan Ejaz
EREdward A. Ross
Edward A. Ross
Background: Continuous renal replacement therapy is widely used for the treatment of critically ill patients with acute renal failure in critical care units. The survival time of the extracorporeal circuit is an important factor in providing renal replacement therapy. Despite rigorous efforts to maintain hemofilter patency, clinicians are occasionally faced with an unexplained short circuit survival time. Methods: We present a critically ill patient undergoing continuous venovenous hemofiltration with regional citrate anticoagulation for management of acute renal failure in the context of sepsis. Once the patient was started on lipid infusion as part of total parenteral nutrition, we observed a shortened circuit survival due to premature hemofilter failure necessitating frequent changes of the hemofilter. The known potential causes for this phenomenon were ruled out. Results: Evaluation revealed grossly lipemic serum associated with severe hypertriglyceridemia. Discontinuation of the lipid infusion was followed by a rapid return of circuit survival time to its baseline. Evaluation of the hemofilter by electron microscopy revealed that the rapid blockage of the hollow fibers was caused by lipid microparticles and fibrin deposits. Conclusion: Since total parenteral nutrition is commonly administered to malnourished and hypercatabolic critically ill patients on continuous renal replacement therapy, we suggest that intravenous lipid therapy might be a previously unreported and unappreciated remediable cause of premature hemofilter failure.

1 May 2011 in Current Rheumatology Reviews
Verified
Journal Article
Closed access
PDF file
MLMiguel A. Lanaspa
Miguel A. Lanaspa
YSYuri Y. Sautin
Yuri Y. Sautin
AEA. Ahsan Ejaz
A. Ahsan Ejaz
MMMagdalena Madero
Magdalena Madero
MLMyPhuong Le
MyPhuong Le
Richard J JohnsonRichard J Johnson
Richard J Johnson
An elevated uric acid is common in subjects with insulin resistance and obesity, and is in effect part of the metabolic syndrome complex. In this paper we review evidence for a potential causal role of uric acid in the metabolic syndrome. While some studies suggest that uric acid may simply be a consequence of the presence of oxidative stress or hyperinsulinemia present in subjects with metabolic syndrome, there is increasing evidence that uric acid could have a contributory causal role. First, an elevated serum uric acid often precedes the development of obesity and metabolic syndrome. Second, experimental and clinical studies provide increasing evidence that excessive intake of fructose, primarily in the form of added sugars, may have a key role in the development of metabolic syndrome. Fructose increases uric acid levels, and lowering uric acid in fructose fed rats can improve insulin resistance and features of metabolic syndrome. The mechanism may be via the improvement in endothelial function and due to direct actions of uric acid on adipocytes. However, the lowering of uric acid in human subjects ingesting high doses of fructose was associated with improvement in blood pressure but not in other features of metabolic syndrome. Clearly more studies are needed to better understand the role of uric acid in metabolic syndrome, but it seems likely that uric acid may have a role as both a marker and potential modifier of the metabolic syndrome.

27 March 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
MSMadiha Shadab
Madiha Shadab
AAAnsar Ahmed Abbasi
Ansar Ahmed Abbasi
AEAhsan Ejaz
Ahsan Ejaz
Afif Ben-MahmoudAfif Ben-Mahmoud
Afif Ben-Mahmoud
VGVijay Gupta
Vijay Gupta
BVBarbara Vona
Barbara Vona
Hearing loss is a clinically and genetically heterogeneous disorder, with over 148 genes and 170 loci associated with its pathogenesis. The spectrum and frequency of causal variants vary across different genetic ancestries and are more prevalent in populations that practice consanguineous marriages. Pakistan has a rich history of autosomal recessive gene discovery related to non‐syndromic hearing loss. Since the first linkage analysis with a Pakistani family that led to the mapping of the DFNB1 locus on chromosome 13, 51 genes associated with this disorder have been identified in this population. Among these, 13 of the most prevalent genes, namely CDH23, CIB2, CLDN14, GJB2, HGF, MARVELD2, MYO7A, MYO15A, MSRB3, OTOF, SLC26A4, TMC1 and TMPRSS3, account for more than half of all cases of profound hearing loss, while the prevalence of other genes is less than 2% individually. In this review, we discuss the most common autosomal recessive non‐syndromic hearing loss genes in Pakistani individuals as well as the genetic mapping and sequencing approaches used to discover them. Furthermore, we identified enriched gene ontology terms and common pathways involved in these 51 autosomal recessive non‐syndromic hearing loss genes to gain a better understanding of the underlying mechanisms. Establishing a molecular understanding of the disorder may aid in reducing its future prevalence by enabling timely diagnostics and genetic counselling, leading to more effective clinical management and treatments of hearing loss.


1 July 2021 in Materials Science and Technology
Verified
Journal Article
Closed access
XGXiong Gao
Xiong Gao
MWMeiling Wang
Meiling Wang
TLTingguang Liu
Tingguang Liu
YLYonghao Lu
Yonghao Lu
AEAhsan Ejaz
Ahsan Ejaz
The grain boundary character distributions of TP347H stainless steel after different thermo-mechanical processes in terms of grain boundary engineering (GBE) were investigated by EBSD. DL-EPR and electrolytic oxalic acid etch tests were carried out to evaluate the improvement of GBE treatment on intergranular corrosion. The low-Σ CSL grain boundary proportion of the TP347H can be increased to about 90% through a single-step thermo-mechanical treatment consisted of a slight tensile deformation (3%) and subsequent annealing process at 1150°C for 1 h. Compared with conventional TP347H, the optimum GBE microstructure suppressed intergranular corrosion due to the high proportion of low-Σ CSL grain boundaries, particularly the twin (Σ3) boundaries which is almost immune to intergranular corrosion.

20 January 2025 in Ceramics International
Verified
Journal Article
Closed access
KBKai Bai
Kai Bai
KQKemian Qin
Kemian Qin
ZJZhaoxuan Jin
Zhaoxuan Jin
BZBuyun Zhang
Buyun Zhang
YWYuchuan Wang
Yuchuan Wang
HPHaibo Peng
Haibo Peng